AMETEK, Inc. ( AME ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Kevin Coleman - VP of Investor Relations & Treasurer David Zapico - Chairman of the Board & CEO Dalip Puri - Executive VP & CFO Conference Call Participants Deane Dray - RBC Capital Markets, Research Division Matt Summerville - D.A. Davidson & Co., Research Division Andrew Obin - BofA Securities, Research Division Christopher Snyder - Morgan Stanley, Research Division Julian Mitchell - Barclays Bank PLC, Research Division Robert Wertheimer - Melius Research LLC Andrew Buscaglia - BNP Paribas Exane, Research Division Nigel Coe …

Baxter International Inc. ( BAX ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Kevin Moran Andrew Hider - CEO, President & Director Joel Grade - Executive VP & CFO Conference Call Participants Robert Marcus - JPMorgan Chase & Co, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Travis Steed - BofA Securities, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Joanne Wuensch - Citigroup Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Matthew Taylor - Jefferies LLC, Research Division Matthew Miksic - Barclays Bank PLC, …

Bandwidth Inc. ( BAND ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Sarah Walas - Vice President of Investor Relations David Morken - Co-Founder, CEO, & Chairman Daryl Raiford - Executive VP & CFO John Bell - Chief Product Officer Conference Call Participants Patrick Walravens - Citizens JMP Securities, LLC, Research Division Joshua Reilly - Needham & Company, LLC, Research Division James Fish - Piper Sandler & Co., Research Division William Power - Robert W. Baird & Co. Incorporated, Research Division Presentation Operator Good morning, and welcome to the Bandwidth Inc. Third Quarter 2025 Earnings …

LKQ Corporation ( LKQ ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Joseph Boutross - Vice President of Investor Relations Justin Jude - President, CEO & Director Rick Galloway - Senior VP & CFO Conference Call Participants Craig Kennison - Robert W. Baird & Co. Incorporated, Research Division Jash Patwa - JPMorgan Chase & Co, Research Division Patrick Buckley - Jefferies LLC, Research Division Presentation Operator Hello, everyone.

Cimpress plc ( CMPR ) Q1 2026 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Meredith Burns - Vice President of Investor Relations Robert Keane - Founder, Chairman & CEO Sean Quinn - Executive VP & CFO Presentation Operator Good morning, and thank you for standing by. Welcome to Cimpress' First Quarter Fiscal Year 2026 Earnings Follow-up Call.

Three industrial stocks-AptarGroup, Tennant and Sealed Air-look poised to beat Q3 earnings, driven by strong end-market demand and pricing gains.

PSA posts higher Q3 FFO and revenues, fueled by rent gains and acquisitions, and lifts its 2025 outlook on stabilizing operations.

EXR tops Q3 FFO estimates with occupancy gains, but rising expenses and interest costs weigh on results.

Core Scientific will remain public after it failed to secure the votes necessary to approve the $9 billion all-stock merger.

Strong sales of Eli Lilly's weight-loss treatments Mounjaro and Zepbound helped power strong quarterly earnings, and the drugmaker boosted its outlook.

Lloyds and Santander were the worst affected by bank account switching in the past quarter, with Barclays also one of the major net losers. Santander UK (LSE:BNC) saw a net 23,000 account switches between July and September 2025, the largest for an individual lending brand, as over 33,000 accounts were closed and over 10,000 added.

TransMedics shares dropped after Q3 results beat consensus but missed high investor expectations, creating a favorable entry point. Q3 is seasonally weak for TMDX, but the current selloff makes valuation attractive and expectations more reasonable. Industry data signals a strong Q4 ahead, supporting the case for near-term upside in TMDX.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Marex To Contact Him Directly To Discuss Their Options

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--National Beverage Corp. (NASDAQ: FIZZ) announced that it had begun open market purchases of its common stock and will release further details at an appropriate time. The purchases were made pursuant to the Company's previously announced share buyback program. “Our Company remains fundamentally strong and continues to generate superior cash flows. Geopolitical headwinds, including the current government shutdown, funding of the SNAP program, tariffs and th.

Roblox Corp (NYSE:RBLX) shares fell about 10% following the company's third quarter earnings report, as investors met higher costs with caution, despite strong revenue growth and better-than-expected earnings. The video-game platform reported a net loss of $257.4 million for Q3, widening from a $240.4 million loss a year earlier.

Merck & Co Inc (NYSE:MRK, ETR:6MK) on Thursday reported third quarter 2025 earnings and revenue that surpassed Wall Street expectations, lifted by strong demand for its cancer immunotherapy Keytruda, but reduced its full-year sales outlook to reflect lower estimated tariff costs, among other factors. The pharmaceutical company's revenue for the quarter rose 4% year over year to $17.28 billion, exceeding the $16.96 billion analyst consensus estimate provided by LSEG.

OSK beats Q3 earnings estimates despite weaker sales, but trims its 2025 outlook amid softer Access and Transport demand.

MAA's Q3 results highlight a slight FFO miss and softer same-store revenues, but low resident turnover and active development plans support stability.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options

Shell PLC's (LSE:SHEL, NYSE:SHEL) third-quarter update offered few surprises but plenty of reassurance. UBS kept its “buy” rating and a price target of 3,050p, noting that the oil major's numbers were solid across the board, with cash flow and balance sheet trends both pointing the right way.